Research Outputs

Permanent URI for this communityhttps://hdl.handle.net/20.500.14288/2

Browse

Filters

2015 - 201912020 - 20222

Advanced Search

Filter by

Settings

Subject: search.filters.subject.Nanomedicine

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    PublicationRestricted
    Development of Ag2SPEI theranostic nanoparticles
    (Koç University, 2015) Aşık, Didar; Acar, Havva Funda Yağcı; 0000-0001-5601-8814; Koç University Graduate School of Sciences and Engineering; Materials Science and Engineering; 178902
  • Thumbnail Image
    PublicationRestricted
    Development of cancer cell selective photodynamic therapy agents & bi-chemiluminescent probes for tumor imaging
    (Koç University, 2022) Almammadov, Toghrul; Kölemen, Safacan; 0000-0003-4162-5587; Koç University Graduate School of Sciences and Engineering; Chemistry; 272051
  • Placeholder
    PublicationMetadata only
    Near infrared light activated upconversion nanoparticles (UCNP) based photodynamic therapy of prostate cancers: an in vitro study
    (Elsevier B.V., 2021) Güleryüz, Burcu; Gülsoy, Murat; Department of Chemistry; Ünal, Uğur; Faculty Member; Department of Chemistry; College of Sciences; 42079
    Photodynamic therapy (PDT), has a potential to cure cancerous prostate tissue with minimal side effects. Traditional PDT, however, mostly utilized visible (VIS) light range with direct application of hydrophobic photosensitizers which may not be adequate in clinical practice for especially deep-seated cancer cells because of poor penetration of VIS wavelengths. Here, we report near infrared light (NIR) induced and dual photosensitizers (PS) encapsulated PDT strategy to reduce prostate cancer cells - PC3. The designed nanoplatform (MC540/ZnPc-UCNP@Au), in this study, include upconversion nanoparticles (UCNP) synthesis to convert NIR light into multiple VIS wavelengths, porous silica coating to upload dual photosensitizers (MC540/ZnPc), and gold (Au) functionalization to enhance PDT treatment. High chemical stabilization provided MC540/ZnPc-UCNP@Au show excellent biocompatibility, and efficient PDT treatment for prostate cancer cells. In fact, the fluorescence of the synthesized nanoplatforms, upon NIR light excitation, can produce considerable amount of ROS in 5 min, as it is well matched with the absorption of MC540, ZnPc and Au nanoparticles (np). In addition, the easy visualization of cellular internalized/adsorbed nanoplatforms reveal the in situ cell imaging possibility for diagnosis. Based on the evidence of the results, NIR light activated MC540/ZnPc-UCNP@Au may offer a PDT technique for the treatment of prostate cancer.